![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Risk of HCC in Patients With HBV Infection
With and Without HIV Coinfection: a US
Administrative Claims Analysis
|
|
|
AASLD 2020 Nov 11-16
Reported by Jules Levin
Susanna Naggie,1 Laura E. Telep,2 Tom McQuaid,2 Heribert Ramroth,2 Anuj Gaggar,2 John Flaherty,2 Anand P. Chokkalingam,2 Mark S. Sulkowski3
1Duke University School of Medicine, Durham, NC; 2Gilead Sciences, Inc., Foster City, CA; 3Johns Hopkins University School of Medicine, Baltimore, MD
![1120201](../images/112020/112020-16/1120201.gif)
![1120202](../images/112020/112020-16/1120202.gif)
![1120203](../images/112020/112020-16/1120203.gif)
![1120204](../images/112020/112020-16/1120204.gif)
![1120205](../images/112020/112020-16/1120205.gif)
References: 1. Bouvard V, et al. Lancet Oncol 2009;10:321-2. 2. Parkin DM. Int J Cancer 2006;118:3030-44; 3. Thio CL, et al. Lancet 2002;360:1921-6.
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|